Abstract
Infective endocarditis despite advances in diagnosis remains a common cause of hospitalization, with high morbidity and mortality rates. Through literature review it is possible to conclude that polymicrobial endocarditis occurs mainly in intravenous drug abusers with predominance in the right side of the heart, often with tricuspid valve involvement. This fact can be associated with the type of drug used by the patients; therefore, knowledge of the patient's history is critical for adjustment of the therapy. It is also important to emphasize that the most common combinations of organisms in polymicrobial infective endocarditis are: Staphylococcus aureus, Streptococcus pneumonia and Pseudomonas aeruginosa, as well as mixed cultures of Candida spp. and bacteria. A better understanding of the epidemiology and associated risk factors are required in order to develop an efficient therapy, although PE studies are difficult to perform due to the rarity of cases and lack of prospective cohorts.
Similar content being viewed by others
References
Horstkotte D, Follath F, Gutschik E et al (2004) Guidelines on prevention, diagnosis and treatment of infective endocarditis. Eur Heart J 25:267–276
Mylonakis E, Calderwood SB (2001) Infective endocarditis in adults. N Engl J Med 345:1318–1330
Elliott TSJ, Foweraker J, Gould FK et al (2004) Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 54:971–981
Sousa C, Henriques M, Oliveira R (2011) Mini-review: antimicrobial central venous catheters–recent advances and strategies. Biofouling 27(6):609–620
Netzer RO, Zollinger E, Seiler C et al (2000) Infective endocarditis: Clinical spectrum, presentation and outcome. An analysis of 212 cases: 1980–1995. Heart 84:25–30
Wang A, Athan E, Pappas PA et al (2007) Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA 297:1354–1361
Rostagno C, Rosso G, Puggelli F et al (2010) Active infective endocarditis: Clinical characteristics and factors related to hospital mortality. Cardiol J 17:566–573
Sedgwick JF, Burstow DJ (2012) Update on echocardiography in the management of infective endocarditis. Curr Infect Dis Rep. Apr 29. [Epub ahead of print]
Bayer AS, Bolger AF, Taubert KA et al (1998) Diagnosis and management of infective endocarditis and its complications. Circulation 22–29(98):2936–2948
Nagji G, Rémadi JP, Coviaux F et al (2005) Comparison of clinical and morphological characteristics of Staphylococcus endocarditis with endocarditis caused by other pathogens. Heart 91:932–937
Leitman M, Dreznik Y, Tyomkin V et al (2012) Vegetation size in patients with infective endocarditis. Eur Heart J Cardiovasc Imaging 13(4):330–338
Bouza E, Menasalvas A, Munoz P et al (2001) Infective endocarditis: a prospective study at the end of the twentieth century-new predisposing conditions, new etiologic agents, and still a high mortality. Medicine 80:298–307
Prendergast BD (2006) The changing face of infective endocarditis. Heart 92:879–885
Karchmer AW, Gibbons GW (1994) Infections of prosthetic heart valves andvascular grafts. In: Bisno AL (ed) Infections Associated With Indwelling Medical Devices. American Society for Microbiology, Washington, DC
Moyer D, Edwards JE (1992) Fungal endocarditis. In: Kaye D (ed) Infective Endocarditis. Raven Press, New York
Moreillon P, Que Y (2004) Infective endocarditis. Lancet 363:139–149
Cooper HL, Brady JE, Ciccarone D et al (2007) Nationwide increase in the number of hospitalizations for illicit injection drug use-related infective endocarditis. Clin Infect Dis 45:1200–1203
Gebo KA, Burkey MD, Lucas GM et al (2006) Incidence of, risk factors for clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort. J Acquir Immune Defic Syndr 43:426–432
Wilson LE, Thomas DL, Astemborski J et al (2002) Prospective study of infective endocarditis among injection drug users. J Infect Dis 185:1761–1766
Fowler VG Jr, Miro JM, Hoen B et al (2005) Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293:3012–3021
Ellis ME, Al-Abdely H, Sandridge A et al (2001) Fungal endocarditis: evidence in the world literature, 1965–1995. Clin Infect Dis 32:50–62
Shively BK (2003) Infective endocarditis. In: M. Crawdord (ed) Current Diagnosis & Treatment in Cardiology. McGraw Hill
Miró JM, del Rio A, Mestres CA (1997) Infective endocarditis in intravenous drug abusers and HIV-1 infected patients. Infect Dis Clin North Am 16:273–295
Araújo IR, Nunes Mdo C, Gelape CL et al (2012) Challenge in the management of infective endocarditis with multiple valvular involvement. Rev Soc Bras Med Trop 45(2):272–274
Moss R, Munt B (2003) Injection drug use and right sided endocarditis. Heart 89:577–581
Brown P, Levine D (2002) Infective endocarditis in the injection drug user. Infect Dis Clin N Am 16:645–665
Mathew J, Addai T, Anand A et al (1995) Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users. Arch Intern Med 155:1641–1648
Carozza A, De Santo LS, Romano G et al (2006) Infective endocarditis in intravenous drug abusers: patterns of presentation and long-term outcomes of surgical treatment. J Heart Valve Dis 15:125–131
San Roman JA, Vilacosta I, Sarria C et al (2001) Eustachian valve endocarditis: is it worth searching for? Am Heart J 142:1037–1040
Kim N, Lazar JM, Cunha BA et al (2000) Multivalvular endocarditis. Clin Microbiol Infect 6:207–212
Oh S, Havlen PR, Hussain N et al (2005) A case of polymicrobial endocarditis caused by anaerobic organisms in an injection drug user. J Gen Intern Med 20:C1–C2
Levine DP, Crane LR, Zervos MJ (1986) Bacteremia in narcotic addicts at the Detroit Medical Center. II. Infectious endocarditis: a prospective comparative study. Rev Infect Dis 8:374–396
Jain V, Yang MH, Kovacicova-Lezcano G et al (2008) Infective endocarditis in an urban medical center: association of individual drugs with valvular involvement. J Infect 57:132–138
Saydain G, Singh J, Dalal B et al (2010) Outcome of patients with injection drug use-associated endocarditis admitted to an intensive care unit. J Crit Care 25:248–253
Lee CY, Chang TM, Lin CJ et al (2012) Infective endocarditis caused by community-associated methicillin-resistant Staphylococcus aureus in a previously healthy preschool child. J Microbiol Immunol Infect. May 8. [Epub ahead of print]
Cherubin CE, Sapira JD (1993) The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later. Ann Intern Med 119:1017–1028
Crane LR, Levine DP, Zervos MJ et al (1986) Bacteremia in narcotic addicts at the Detroit Medical Center. I. Microbiology, epidemiology, risk factors, and empiric therapy. Rev Infect Dis 8:364–373
Botsford KB, Weinstein RA, Nathan CR et al (1985) Selective survival in pentazocine and tripelennamine of Pseudomonas aeruginosa serotype O11 from drug addicts. J Infect Dis 151:209–216
Bisbe J, Miro JM, Latorre X et al (1992) Disseminated candidiasis in addicts who use brown heroin: report of 83 cases and review. Clin Infect Dis 15:910–923
Brito LR, Guimarães T, Nucci M et al (2006) Clinical and microbiological aspects of candidemia due to Candida parapsilosis in Brazilian tertiary care hospitals. Med Mycol 44:261–266
Daas H, Abuhmaid F, Zervos M (2009) Successful treatment of Candida parapsilosis and Pseudomonas aeruginosa infection using medical and surgical management in an injecting drug user with mitral and aortic valve endocarditis: a case report. J Med Case Rep 3:6598
Baddour LM, Meyer J, Henry B (1991) Polymicrobial infective endocarditis in the 1980s. Rev Infect Dis 13:963–970
Wang'ondu RW, Murray TS (2011) Relapse of polymicrobial endocarditis in an intravenous drug user. Yale J Biol Med 84(3):321–324
Houry D, Crisman T (1999) Bivalve polymicrobial infective endocarditis. South Med J 1098–1099
Saravolatz LD, Burch KH, Quinn EL et al (1978) Polymicrobial infective endocarditis: an increasing clinical entity. Am Heart J 95:163–168
Adler AG, Blumberg EA, Schwartz DA et al (1991) Seven-pathogen tricuspid endocarditis in an intravenous drug abuser. Pitfalls in laboratory diagnosis. Chest 99:490–491
Raucher B, Dobkin J, Mandel L et al (1989) Occult polymicrobial endocarditis with Haemophilus parainfluenzae in intravenous drug abusers. Am J Med 86:169–172
Mager DL, Ximenez-Fyvie LA, Haffajee AD et al (2003) Distribution of selected bacterial species on intraoral surfaces. J Clin Periodontol 30:644–654
Tran C, Cometta A, Letovanec I et al (2007) Candida dubliniensis in recurrent polymicrobial tricuspid endocarditis. Echocardiogr 24:756–759
Baddley JW, Benjamin DK Jr, Patel M, International Collaboration on Endocarditis-Prospective Cohort Study Group (ICE-PCS) et al (2008) Candida infective endocarditis. Eur J Clin Microbiol Infect Dis 27:519–529
Benjamin DK Jr, Miro JM, Hoen B et al (2004) Candida endocarditis: contemporary cases from the International Collaboration of Infectious Endocarditis Merged Database (ICE-mD). Scand J Infect Dis 36:453–455
Acknowledgments
This work was supported by Portuguese Foundation for Science and Technology (FCT) through the grants SFRH/BPD/47693/2008, SFRH/BPD/20987/2004 and SFRH/BPD/72632/2010 attributed to Cláudia Sousa, Cláudia Botelho and Diana Rodrigues, respectively.
Conflict of interest
There is no conflict of interest.
Author’s knowledge
All authors had access to the data and a role in writing the manuscript
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sousa, C., Botelho, C., Rodrigues, D. et al. Infective endocarditis in intravenous drug abusers: an update. Eur J Clin Microbiol Infect Dis 31, 2905–2910 (2012). https://doi.org/10.1007/s10096-012-1675-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-012-1675-x